IO Biotech, Inc. (IOBTQ) Other Accumulated Expenses (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Other Accumulated Expenses data on file, last reported at $491000.0 in Q3 2025.

• Quarterly Other Accumulated Expenses fell 47.6% year-over-year to $491000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $491000.0 (down 47.6% YoY) and the FY2024 annual result came in at $500000.0, down 11.19% from the prior year.
• Other Accumulated Expenses rose to $491000.0 in Q3 2025, from $416000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.0 million in Q1 2023 to a low of $350000.0 in Q3 2021.
• A 5-year average of $732235.3 and a median of $506000.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 323.21% — and 2023, when it sank 71.14%.
• Tracing IOBTQ's Other Accumulated Expenses over 5 years: stood at $461000.0 in 2021, then jumped by 323.21% to $2.0 million in 2022, then slumped by 71.14% to $563000.0 in 2023, then retreated by 11.19% to $500000.0 in 2024, then retreated by 1.8% to $491000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $491000.0 (Q3 2025), $416000.0 (Q2 2025), and $506000.0 (Q1 2025), per Business Quant data.